Literature DB >> 7994502

Depression in Parkinson's disease. A positron emission study.

H A Ring1, C J Bench, M R Trimble, D J Brooks, R S Frackowiak, R J Dolan.   

Abstract

BACKGROUND: This study investigated biological correlates of depression in patients with idiopathic Parkinson's disease (PD). We tested the hypothesis that in patients with PD and depression, there was regional dysfunction involving brain areas previously implicated in functional imaging studies of patients with primary depression.
METHOD: Using positron emission tomographic measurements of regional cerebral blood flow (rCBF), patterns of resting rCBF were measured in ten patients with PD and major depression, and ten patients with PD alone. The results were compared with findings from ten patients with primary depression and ten normal controls, scanned using identical methods as part of an earlier study. Groups were matched for age, sex and symptom severity.
RESULTS: Bilateral decreases in rCBF were observed in anteromedial regions of the medial frontal cortex and the cingulate cortex (Brodmann's areas (BA) 9 and 32) in the depressed PD group, compared with those with PD alone and compared with normal controls. This regional disturbance overlapped that observed in patients with primary depression.
CONCLUSIONS: The findings indicate that the medial prefrontal cortex is a common area of neural dysfunction in the manifestation of both primary depression and depression in PD.

Entities:  

Mesh:

Year:  1994        PMID: 7994502     DOI: 10.1192/bjp.165.3.333

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  36 in total

1.  Brain mechanisms of stress and depression in coronary artery disease.

Authors:  J Douglas Bremner; Carolina Campanella; Zehra Khan; Negar Fani; Nicole Kasher; Sarah Evans; Collin Reiff; Sanskriti Mishra; Stacy Ladd; Jonathon A Nye; Paolo Raggi; Viola Vaccarino
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

2.  Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Alexander I Tröster; Jade Tiu Rubino; Lesley A Allen; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

Review 3.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

5.  Cortical thinning in drug-naive Parkinson's disease patients with depression.

Authors:  ChunYan Luo; Wei Song; Qin Chen; Jing Yang; QiYong Gong; Hui-Fang Shang
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

6.  Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Eric Vermetten; Dennis S Charney
Journal:  J Affect Disord       Date:  2006-12-19       Impact factor: 4.839

7.  Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.

Authors:  Gregor Hasler; Stephen Fromm; Paul J Carlson; David A Luckenbaugh; Tracy Waldeck; Marilla Geraci; Jonathan P Roiser; Alexander Neumeister; Noah Meyers; Dennis S Charney; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 8.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 9.  Comparison of prefrontal cell pathology between depression and alcohol dependence.

Authors:  José J Miguel-Hidalgo; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2003 Sep-Oct       Impact factor: 4.791

Review 10.  Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Authors:  Paul J Carlson; Jaskaran B Singh; Carlos A Zarate; Wayne C Drevets; Husseini K Manji
Journal:  NeuroRx       Date:  2006-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.